Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
Federal Reserve Vice Chair Richard Clarida said Friday that the global economy has deteriorated in the past month.Marketsread more
The latest escalation in the trade war ups the odds the economy will fall into recession and that the Fed will aggressively cut rates.Market Insiderread more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
"We don't need China and, frankly, would be far better off without them," Trump tweeted.Politicsread more
"My only question is, who is our bigger enemy, Jay Powell or Chairman Xi?" Trump wrote amid a series of tweets that rattled markets Friday.Politicsread more
"I would love this to be clarified. We come to a deal on trade, boy, this market is up 10 to 15%, but without it's going to be worrisome," Jeremy Siegel says.Marketsread more
The final week of August could be highly volatile as markets fret over the economy and the latest developments in trade wars.Market Insiderread more
The death comes as federal and state health officials investigate a slew of lung illnesses in connection to e-cigarette use.Health and Scienceread more
Bank of England Governor Mark Carney says trade war has a confidence effect on business around the worldMarketsread more
Andy Salamon, a former lieutenant in the U.S. Navy, watched his father struggle with undiagnosed sleep apnea, which occurs when the airway gets blocked during sleep.
"It was years, and a lot of nudging from the family for him to do something," Salamon said, in an exclusive interview with CNBC, announcing the launch of his new company Rested. "And then it took months to get help through a visit to the doctor, a referral to a specialist and lab tests before he could get treated."
With Rested, Salamon wants to help people determine if they're at risk for sleep disorders -- and get the assistance they need. He's hoping that by digitizing many of the traditional processes, such as offering virtual doctor visits, he can dramatically reduce the costs of getting diagnosed and treated.
Rested, which has raised $7.4 million in venture capital, offers a free service that assesses risk for sleep problems and provides coaching to help people sleep better. It also has a paid offering, which includes an in-app consultation with a doctor who can make a diagnosis after viewing the results from a home sleep test. That's much easier and cheaper than traveling to a sleep center for an overnight stay, said Salamon.
Rested also enables virtual visits with a respiratory therapist via the app, allowing experts to remotely fit the user with a sleep mask.
With the new financing, Rested is expanding nationwide. Currently, the beta service is only available in Maryland, Pennsylvania, Washington D.C. and Virginia.
About 50 million to 70 million people in the U.S. have a sleep or wakefulness disorder, according to the Center for Disease Control and Prevention, making it a compelling opportunity for technology entrepreneurs. Rested is focusing on software, rather than manufacturing its own devices -- but it's not ruling that out in the future.
Rested determines if a person is at low, high or medium risk for a sleep disorder like sleep apnea through a survey, which includes questions about body mass index and gender as well as a "sleep score" that weighs hours in bed, sounds during the night and time asleep.
It also lets users record their sleep sounds, which might prove jarring for those who don't realize that they're snoring extremely loudly or they've stopped breathing during the night.
Those who choose to get a diagnosis and seek treatment with Rested have the option to use their insurance or pay out-of-pocket, Salamon said.
He estimates that without insurance the price for Rested's service is about $1,000, which includes the doctor's visit, the at-home diagnostic test and the equipment to treat the disease. That compares to a cash charge of about $6,000 or $7,000 to do this all in person through the traditional medical processes.
With insurance, the price might drop, depending on the plan.
Going forward, Salamon, who previously worked at hedge funds, sees opportunities to partner with payers, including self-insured employers. If untreated, sleep apnea can lead to expensive health problems down the line, public safety issues and hours of lost productivity, he said.